Lovisa V.
- Country
- Sweden
- Department
- Hematology and Coagulation
Research Overview
- Evaluation of Triptorelin for Ovarian Reserve Preservation in Young Females Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas
- Efficacy and Safety of Ropeginterferon Alfa-2b with Bosutinib in Chronic Myeloid Leukemia: A Randomized Prospective Trial
- Evaluation of Revumenib Combined with Azacitidine and Venetoclax in Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML Patients Ineligible for Intensive Chemotherapy
Data & Insights
Has run more than one trial at 92 of 182 partner sites.
Specializations
Hematologic malignancies and cellular therapy
Clinical research activity includes acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, myelodysplastic syndromes, multiple myeloma, lymphoma, and graft-versus-host disease, with involvement in studies spanning relapsed and newly diagnosed blood cancers as well as CAR T-cell therapy and stem cell transplantation settings.
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Multiple myeloma
- CAR T-cell therapy
The therapeutic focus extends across hematology, with interest in treatment-resistant disease, immune-mediated complications, and novel approaches for malignant and post-transplant blood disorders.
Cardiovascular disease and thromboembolic prevention
Research involvement covers atrial fibrillation, heart failure, ischemic stroke, coronary artery disease, pulmonary hypertension, hypertension, and atherosclerotic cardiovascular disease, including studies focused on rhythm control, stroke prevention, and outcomes in patients with complex cardiovascular risk profiles.
- Atrial fibrillation
- Heart failure
- Ischemic stroke
- Pulmonary arterial hypertension
Additional activity includes cardiac surgery-related complications, Takotsubo syndrome, and prevention strategies for embolic events and vascular disease.
Solid tumors and oncology
Clinical trial participation spans breast cancer, prostate cancer, lung cancer, colorectal cancer, pancreatic cancer, melanoma, cholangiocarcinoma, and other advanced solid tumors, with therapeutic interest in both localized and metastatic disease.
- Breast cancer
- Prostate cancer
- Non-small cell lung cancer
- Melanoma
The research landscape also includes targeted therapy, immunotherapy, and treatment optimization in gastrointestinal malignancies and genitourinary cancers.
Neuroimmunology and neurological disorders
Areas of interest include multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, acute ischemic stroke, and other nervous system diseases, reflecting involvement in conditions affecting both neurodegeneration and immune-mediated neurological dysfunction.
- Multiple sclerosis
- Epilepsy
- Parkinson's disease
- Alzheimer's disease
Therapeutic activity also touches neurodevelopmental and rare neurological disorders, including progressive and relapsing disease patterns.
Renal, respiratory, and immune-mediated diseases
Research involvement includes chronic kidney disease, kidney transplant rejection, immunoglobulin A nephropathy, proteinuric glomerular diseases, chronic obstructive pulmonary disease, asthma, cystic fibrosis, atopic dermatitis, Crohn's disease, and ulcerative colitis.
- Chronic kidney disease
- Chronic obstructive pulmonary disease
- Atopic dermatitis
- Inflammatory bowel disease
The therapeutic scope also covers autoimmune disease, transplant medicine, and chronic inflammatory conditions requiring long-term disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.